Evaluating the use of friend or family controls in epidemiologic case-control studies  by Zhong, Charlie et al.
Cancer Epidemiology 46 (2017) 9–13Evaluating the use of friend or family controls in epidemiologic
case-control studies
Charlie Zhonga, Myles Cockburnb, Wendy Cozenb, Jenna Voutsinasa, James V. Lacey Jr.a,
Jianning Luoa, Jane Sullivan-Halleya, Leslie Bernsteina, Sophia S. Wang, Ph.Da,*
aDepartment of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, United States
bDivision of Preventive Medicine, University of Southern California and the Keck School of Medicine, Los Angeles, CA, United States
A R T I C L E I N F O
Article history:
Received 26 July 2016
Received in revised form 27 September 2016






A B S T R A C T
Background: Traditional methodologies for identifying and recruiting controls in epidemiologic case-
control studies, such as random digit dialing or neighborhood walk, suffer from declining response rates.
Here, we revisit the feasibility and comparability of using alternative sources of controls, speciﬁcally
friend and family controls.
Methods: We recruited from a recently completed case-control study of non-Hodgkin lymphoma (NHL)
among women in Los Angeles County where controls from the parent study were ascertained by
neighborhood walk. We calculated participation rates and compared questionnaire responses between
the friend/family controls and the original matched controls from the parent study.
Results: Of the 182 NHL case patients contacted, 111 (61%) agreed to participate in our feasibility study. 70
(63%) provided contact information for potential friend and/or family member controls. We were able to
successfully contact and recruit a friend/family member for 92% of the case patients. This represented
46 friend controls and 54 family controls. Family controls signiﬁcantly differed from original matched
controls by sex and household income. Other characteristics were similar between friend controls and
the original study’s neighborhood controls.
Conclusion: The apparent comparability of neighborhood controls to friend and family controls among
respondents in this study suggests that these alternative methods of control identiﬁcation can serve as a
complementary source of eligible controls in epidemiologic case-control studies.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A present challenge in conducting epidemiologic case-control
studies is the identiﬁcation and recruitment of suitable controls in
a cost-efﬁcient manner. The response rates, and resulting validity,
of widely used approaches for recruitment of population-based
controls, such as random digit dialing (RDD) and neighborhood
walk, have declined. Response rates for RDD have fallen from 75–
80% in the 1980s to 55–60% in the 2000s [1–5], largely attributed to
the use of caller identiﬁcation and increasing cellular phone usage
[6]. Falling response rates increase the amount of resources
required to identify suitable controls, particularly for approaches
like neighborhood walk [7] and for some minority populationsAbbreviations: RDD, random digit dialing; NHL, non-Hodgkin lymphoma.
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1877-7821/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article unwhich require multiple follow-up attempts to ascertain a
successful recruit [8,9].
Alternative strategies for identifying and recruiting controls
have been proposed. Given the rise in number of households who
rely on cell phones as their primary or exclusive mode of
communication [10], one alternative strategy is by modifying
RDD to incorporate cell phone numbers in place of or in
conjunction with traditional landline RDD [11]. However, area
codes are not necessarily indicative of geographical location and
the use of caller ID may prevent case patients from answering calls
from unknown numbers [11,12]. Long-debated alternative meth-
ods for epidemiologic recruitment of controls include recruitment
of case patients’ friends and/or case patients’ family members [13–
16]. These methods have not been widely employed because of
possible limitations, including: (i) potential overmatching of
controls by exposures, as friend and family tend to engage in
similar behaviors and live in similar areas (should certain
exposures be of interest) [17–19] and (ii) potential bias among
friend controls towards extroverts whereby introvert case patientsder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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who case patients nominate [18]. However, for some scientiﬁc
questions, the use of such controls could be suitable; speciﬁcally,
the use of family controls is considered a strength for studies aimed
at identifying gene associations [20–23].
In this manuscript, we assess the feasibility of identifying and
recruiting family or friend controls for epidemiologic case-control
studies. Based on a racially/ethnically diverse 10% sample of female
non-Hodgkin lymphoma (NHL) patients in Los Angeles County, we
evaluated: (i) the willingness of case patients to provide names of
family and/or friends as possible controls; (ii) the willingness of
identiﬁed friend or family controls to participate in an epidemio-
logic study and complete a questionnaire; and (iii) the compara-
bility of the questionnaire responses from participating friend or
family control to controls recruited by neighborhood walk.
2. Materials and methods
2.1. Parent case-control study
From 2004–2008, we conducted a case-control study of
1006 female B-cell non-Hodgkin lymphomas and 1038 matched
controls in Los Angeles County. Case patients were identiﬁed by the
Los Angeles County Cancer Surveillance Program and controls
were recruited by neighborhood walk, matched to case patients
within a 5 year age group, race, and socioeconomic status [24].
Speciﬁcally, recruiting control participants involved walking
neighborhoods and obtaining a census for all households within
the series of addresses to be surveyed, until an eligible matched
control was identiﬁed. This methodology resulted in an 85%
response rate among controls. All case patients were interviewed
in person and asked detailed questions about their health,
including anthropometric characteristics and lifestyle factors.
2.2. Identiﬁcation of alternative controls
We recontacted 182 living NHL case patients and asked if they
were willing to participate in a feasibility study aimed to explore
alternative methods for conducting epidemiologic studies. A case
patient’s willingness to participate upon informed consent was
subsequently followed by a request for names and contact
information of three friends and three family members, preferably
siblings or cousins who were similar in age (within 10 years), race,
and sex to the case patient. Case patients were asked to contact
their respective controls ﬁrst and then to provide the potential
controls’ name and contact information once the potential control
gave their permission for the case patient to do so. We attempted to
recruit and interview each of the family members and friends for
whom we obtained contact information. Upon a potential control’s
consent to participate, an abbreviated version of parent study
questionnaire was administered during a telephone interview.
2.3. Abbreviated questionnaire administration
Among consented controls, the abbreviated questionnaire
included targeted areas of interest delineated in Supplementary
Table S1 in the online version at DOI: http://dx.doi.org/10.1016/j.
canep.2016.10.007: (i) demographics, (ii) lifestyle and behavioral
characteristics, and (among female respondents) (iii) reproductive
characteristics, and (iv) health behavior.
2.4. Analytic methods
First, we calculated the response rates among contacted case
patients representing their willingness to provide names and
contact information for potential friend or family controls deﬁnedas the total number of case patients who agreed to participate
divided by the total number of case patients contacted. Second,
among case patients who consented to participate, we calculated
the response rate for providing the requested information \on
respective friend or family controls. This response rate was
deﬁned as the total number of case patients who agreed to
participate and provided the requested information divided by the
total number of case patients who consented to participate in this
feasibility study. Third, among identiﬁed friends and family
members with contact information whom we attempted to recruit,
we calculated the respective response rates of controls that were
willing to participate in our study. This response rate was deﬁned as
the number of contacted controls who agreed to participate and
completed our questionnaire divided by the total number of
controls contacted. These response rates were calculated overall,
by race/ethnicity, and sex (Table 1).
Finally, we compared demographic information and question-
naire responses of highest ranked family control and friend control
(to approximate a 1:1 matching method) to the responses from the
matched neighborhood matched control that was recruited in the
parent case-control study for the case patient. The following
criteria were used to rank the family and friend controls: (1) same
sex and older than case patient; (2) opposite sex and older; (3)
same sex and younger; (4) opposite sex and younger. We compared
the frequencies (percent) of the questionnaire responses by
calculating the Fisher’s exact test for statistical signiﬁcance using
SAS 9.3 (SAS Institute, Cary, NC). These results are shown in
Supplementary Table S1 in the online version at DOI: http://dx.doi.
org/10.1016/j.canep.2016.10.007%20.
3. Results
3.1. Willingness of case patients to provide names of family and/or
friends to serve as potential controls
Of the 182 living NHL case patients contacted, 111 (61%) agreed
to participate in our feasibility study (Table 1). Of the 111, 40 (36%)
were able to provide names and contact information for potential
family member and friend controls, 19 (17%) were only able to
provide names and contact information for potential family
controls, and 11 (10%) were only able to provide names and
contact information for potential friend controls. There were 41
(37%) case patients who consented to participate but were unable
to provide names/contact information for friends or family, citing
that the potential controls they contacted were unwilling to
participate. The 71 (39%) case patients who did not consent to
participate cited varying reasons, including: (i) not having told any
of their friends or family that they were diagnosed with NHL
(n = 4); (ii) being willing to participate but not having any friend or
family of the same race or general age (n = 14); the remaining
37 were soft refusals whereby the case patient verbally agreed to
participate but was ultimately unable to be reached. Participation
rates were relatively consistent by race/ethnicity.
Of participating case patients, the ability to provide contact
information for potential friend controls was highest among Asians
(60%) and non-Hispanic Whites (60%), and lowest among Blacks
(26%) and Hispanics (29%). The ability to provide contact
information for potential family controls was highest among
Hispanic (62%) and non-Hispanic Whites (60%) and lowest among
Blacks (34%).
3.2. Willingness of identiﬁed friend or family controls to participate in
an epidemiologic study and complete a questionnaire
In all, we attempted to contact 102 potential friend controls
who were identiﬁed by 51 NHL case patients. We were able to
Table 1
Response Rates for NHL Case Patients, Highest Rank Matched Friend, and Highest Rank Matched Family Member Willing to Participate in a Health Study.






Alive and contacted 182 46 45 91 56 35
Agreed to Participate 111 61% 30 65% 27 60% 54 59% 33 59% 21 60%
Nominated both friends and family members 40 36% 15 50% 5 19% 20 37% 16 48% 4 19%
Nominated only friends 11 10% 3 10% 2 7% 6 11% 4 12% 2 10%
Nominated only family members 19 17% 2 7% 4 15% 13 24% 4 12% 9 43%
Agreed to participate but reported no willing
friend or family
41 37% 10 33% 16 59% 15 28% 9 27% 6 29%
Refused (includes nonrespondents after
initial contact)
71 39% 16 35% 18 40% 37 41% 23 41% 14 40%
Highest Rank Friend Controls (1 control per case patient)
Attempted to contact 51 18 7 26 20 6
Able to contact 50 98% 18 100% 7 100% 25 96% 19 95% 6 100%
Completed Questionnaire 46 92% 15 83% 7 100% 24 96% 19 100% 5 83%
Older, same sex 33 72% 13 87% 5 71% 15 63% 13 68% 2 40%
Older, different sex 1 2% 0 0% 0 0% 1 4% 1 5% 0 0%
Younger, same sex 11 24% 2 13% 2 29% 7 29% 5 26% 2 40%
Younger, different sex 1 2% 0 0% 0 0% 1 4% 0 0% 1 20%
Refused 4 8% 3 17% 0 0% 1 4% 0 0% 1 17%
Unable to Contact 1 2% 0 0% 0 0% 1 4% 1 5% 0 0%
Highest Rank Family Members (1 control per case patient)
Attempted to contact 59 17 9 33 20 13
Able to contact 59 100% 17 100% 9 100% 33 100% 20 100% 13 100%
Completed Questionnaire 54 92% 16 94% 9 100% 29 88% 20 100% 9 69%
Older, same sex sibling 16 30% 2 13% 3 33% 11 38% 5 25% 6 67%
Older, same sex cousin 1 2% 0 0% 0 0% 1 3% 1 5% 0 0%
Older, opposite sex sibling 4 7% 2 13% 0 0% 2 7% 2 10% 0 0%
Older, opposite sex cousin 1 2% 0 0% 0 0% 1 3% 0 0% 1 11%
Younger, same sex sibling 22 41% 8 50% 4 44% 10 34% 7 35% 3 33%
Younger, same sex cousin 5 9% 3 19% 1 11% 1 3% 1 5% 0 0%
Younger, opposite sex sibling 5 9% 1 6% 1 11% 3 10% 3 15% 0 0%
Younger, opposite sex cousin 1 2% 0 0% 0 0% 1 3% 1 5% 0 0%
Refused 4 7% 1 6% 0 0% 3 9% 0 0% 3 23%
Unable to Contact 0 0% 0 0% 0 0% 0 0% 0 0% 0 0%
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friend controls contacted, 83 controls (from 46 case patients)
provided consent and completed the questionnaire. Of the
46 highest ranked friend controls (matched 1:1 to each case
patient); 33 were of the same sex and older, 1 was of the opposite
sex and older, 11 were of the same sex and younger, and 1 was of
the opposite sex and younger (Table 1). These distributions did not
appear to vary across racial/ethnic groups.
Of 99 potential family controls (representing 59 case patients),
we successfully contacted 92 potential family controls (represent-
ing all 59 case patients), of which 78 consented and completed a
questionnaire. These 78 family controls were from 54 case
patients, leaving 5 case patients without an identiﬁed family
control. Of the 54 highest ranked controls, 17 were older siblings or
cousins of the same sex, 5 were older siblings or cousins of the
opposite sex, 26 were younger siblings or cousins of the same sex,
and 6 were younger siblings or cousins of the opposite sex
(Table 1).
3.3. Comparability of the questionnaire responses from participating
friend or family control and the original control
Among demographic characteristics, statistically signiﬁcant
(P < 0.05) differences were observed between family controls and
the original controls with respect to sex; the 20% of family controls
who were male reﬂected the difﬁculty in ascertaining family
controls of the same sex for all case patients (see SupplementaryTable S1 in the online version at DOI: http://dx.doi.org/10.1016/j.
canep.2016.10.007%20). Annual household income was also lower
among the family controls. Although not statistically signiﬁcant,
family controls were generally younger than the original
neighborhood controls. Overall, friend controls appeared similar
to the original study’s neighborhood controls.
4. Discussion
Results from our feasibility study testing recruitment of
different types of controls in a racially/ethnically diverse case-
control study of NHL suggest that recruitment of friends and
family members as a primary source of controls present a
signiﬁcant challenge for epidemiologic studies. Nevertheless, the
high response rate among identiﬁed controls makes utilization of
friend or family controls a viable method for supplementing other
methodologies of control ascertainment. Friend controls in
general had a higher response rate than family controls and
their responses to the abbreviated questionnaire were closely
aligned to those of our original neighborhood controls. However,
due to the limited sample size, we cannot exclude the possibility
that similarities between friend and family controls with
population–based controls may be due to chance. As indicated
by Milne and colleagues, another potential consideration for
utilizing family controls is in addressing potential bias of higher
SES among population-based controls[25]. However, we note that
some case patients did not have family members of the same sex,
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controls, potentially introducing corresponding and potentially
critical differences in the timing of certain exposures (i.e. DES).
Case patient response rates were similar across racial/ethnic
groups; however the ability to provide family or friend controls
differed. 40% of the NHL case patients identiﬁed as Black provided
information regarding friend or family member who could serve as
a potential control. Two-thirds of Asian and 73% of non-Hispanic
White NHL case patients provided information on potential
controls, which is consistent with other studies[15,26]. We
required the participating case patients to contact their potential
controls before we made an attempts to do so, likely resulting in
our higher response rate among the controls (92%) compared to
previously reported efforts (48–70%) [13,19,26,27]. We cannot
exclude the possibility of differential participation rates in the
general population when men are included [13,15] as our parent
study was restricted to female NHL case patients. Because the
median age of diagnosis for NHL is 66 years, our ability to identify
older family controls was likely diminished [28]. It is possible that
higher participation rates might be achieved for disease endpoints
with a lower median age of diagnosis.
Prior studies that have used friend or family controls have been
conducted primarily within non-Hispanic White populations and
have reported that 60–100% of case patients provided controls
[13,15,21,26,29–31]. Our response rates for non-Hispanic Whites
were comparable to these previous efforts. Although the success of
this methodology appeared to be equivalent among Asian-
Americans, response rates in our study among Black and Hispanic
populations remained low.
Some case patients refused to participate because they had not
discussed their NHL diagnoses with friends or family members.
The severity of the cancer diagnosis may also impact the
willingness to discuss it with others [14]. Several case patients
also noted they were unable to provide family members who
resided in the United States, which is a particularly important issue
to consider when applying this methodology to immigrant
populations.
Population-based control recruitment, including the parent
study’s neighborhood walk methodology, is resource and time
intensive. Complementary and, arguably, more convenient meth-
ods, such as soliciting information on friends and families to
identify appropriate controls, would contribute towards the overall
efﬁciency in ﬁnding suitable controls. Speciﬁcally, the up-front
effort to query friends and family members is an efﬁcient way to
create a pool of potentially eligible controls, from which we found
in this study to yield higher response rates.
In summary, ascertaining potential friend and family control
information from case patients at the time of case recruitment
could supplement other methodologies, such as RDD or neighbor-
hood walk, for control identiﬁcation and recruitment in epidemi-
ologic studies. Continued efforts to identify and improve
alternative methods [32,33] for control recruitment in popula-
tion-based case-control studies are needed.
Declaration of interests




This work was supported by the City of Hope Tim Nesvig
Lymphoma Research Foundation to S.W. and the NationalInstitutes of Health (grant R01 CA166219 to S.W.;
P30 CA0335722; and R01 CA108634 and P01 CA017054 to L.B.).
Authorship contribution
S.S.W., J.V.L, Jr., and L.B. conceived and designed the study; C.Z.,
J.V., J.L., and J.H. conducted data analysis; S.S.W., J.V.L, Jr., M.C., W.C.,
C.Z., J.V., and L.B. contributed to data interpretation; all authors
contributed to manuscript preparation.
Acknowledgements
We are grateful to our study interviewers, Ms. Cynthia Quince
and Teri Terrusa, whose diligence made this study possible.
The collection of cancer incidence data used in this study was
supported by the California Department of Public Health pursuant
to California Health and Safety Code Section 103885; Centers for
Disease Control and Prevention’s (CDC) National Program of Cancer
Registries, under cooperative agreement 5NU58DP003862-04/
DP003862; the National Cancer Institute’s Surveillance, Epidemi-
ology and End Results Program under contract
HHSN261201000140C awarded to the Cancer Prevention Institute
of California, contract HHSN261201000035C awarded to the
University of Southern California, and contract
HHSN261201000034C awarded to the Public Health Institute.
The ideas and opinions expressed herein are those of the author(s)
and endorsement by the State of California, Department of Public
Health, the National Cancer Institute, and the CDC or their
Contractors and Subcontractors is not intended nor should be
inferred.
References
[1] L.M. Morton, J. Cahill, P. Hartge, Reporting participation in epidemiologic
studies: a survey of practice, Am. J. Epidemiol. 163 (3) (2006) 197–203.
[2] G.R. Bunin, L.G. Spector, A.F. Olshan, L.L. Robison, M. Roesler, S. Grufferman, X.-
o. Shu, J.A. Ross, Secular trends in response rates for controls selected by
random digit dialing in childhood cancer studies: a report from the children's
oncology group, Am. J. Epidemiol. 166 (1) (2007) 109–116.
[3] R. Curtin, S. Presser, E. Singer, Changes in telephone survey nonresponse over
the past quarter century, Public Opin. Q. 69 (1) (2005) 87–98.
[4] S.H. Olson, Reported participation in case-control studies: changes over time,
Am. J. Epidemiol. 154 (6) (2001) 574–581.
[5] S. Galea, M. Tracy, Participation rates in epidemiologic studies, Ann. Epidemiol.
17 (9) (2007) 643–653.
[6] P. Hartge, Participation in population studies, Epidemiology 17 (3) (2006) 252–
254, doi:http://dx.doi.org/10.1097/01.ede.0000209441.24307.92.
[7] L. Bernstein, Control recruitment in population-based case-control studies,
Epidemiology 17 (3) (2006) 255–257, doi:http://dx.doi.org/10.1097/01.
ede.0000209440.94875.42.
[8] A.D. Steffen, L.N. Kolonel, A.M. Nomura, F.S. Nagamine, K.R. Monroe, L.R.
Wilkens, The effect of multiple mailings on recruitment: the multiethnic
cohort, Cancer Epidemiolo. Biomark. Prevent. 17 (2) (2008) 447–454.
[9] S.E. Puumala, L.G. Spector, L.L. Robison, G.R. Bunin, A.F. Olshan, A.M. Linabery,
M.A. Roesler, C.K. Blair, J.A. Ross, Comparability and representativeness of
control groups in a case-control study of infant leukemia: a report from the
children's oncology group, Am. J. Epidemiol. 170 (3) (2009) 379–387.
[10] S.J. Blumberg, J.V. Luke, Wireless Substitution: Early Release of Estimates From
the National Health Interview Survey January-June 2013, in: N.C.f.H.S. Division
of Health Interview Statistics (Ed.), Centers for Disease Control and Prevention,
2013.
[11] L.F. Voigt, S.M. Schwartz, D.R. Doody, S.C. Lee, C.I. Li, Feasibility of including
cellular telephone numbers in random digit dialing for epidemiologic case-
control studies, Am. J. Epidemiol. 173 (1) (2011) 118–126.
[12] A.M. Kempf, P.L. Remington, New challenges for telephone survey research in
the twenty-ﬁrst century, Annu. Rev. Public Health 28 (1) (2007) 113–126.
[13] H. Logan, S. Tomar, M. Chang, G. Turner, W. Mendenhall, C. Riggs, Selecting a
comparison group for 5-year oral and pharyngeal cancer survivors: two
methods, BMC Med. Res. Methodol. 12 (1) (2012) 63.
[14] G.L. Shaw, M.A. Tucker, R.G. Kase, R.N. Hoover, Problems ascertaining friend
controls in a case-control study of lung cancer, Am. J. Epidemiol. 133 (1) (1991)
63–66.
C. Zhong et al. / Cancer Epidemiology 46 (2017) 9–13 13[15] W. Bradford Burke, D.L. Brown, T.G. Brott, R.D. Brown, et al., Spouses and
unrelated friends of probands as controls for stroke genetics studies,
Neuroepidemiology 22 (4) (2003) 239–244.
[16] W.F. Schlech, K.N. Shands, A.L. Reingold, et al., Risk factors for development of
toxic shock syndrome: association with a tampon brand, JAMA 248 (7) (1982)
835–839.
[17] W.D. Flanders, H. Austin, Possibility of selection bias in matched case-control
studies using friend controls, Am. J. Epidemiol. 124 (1) (1986) 150–153.
[18] S. Wacholder, D.T. Silverman, J.K. McLaughlin, J.S. Mandel, Selection of controls
in case-control studies. II. Types of controls, Am. J. Epidemiol. 135 (9) (1992)
1029–1041.
[19] D. Il'yasova, B. McCarthy, J. Marcello, J.M. Schildkraut, P.G. Moorman, B.
Krishnamachari, F. Ali-Osman, D.D. Bigner, F. Davis, Association between
glioma and history of allergies, asthma, and eczema: a case-control study with
three groups of controls, Cancer Epidemiol. Biomark. Prevent. 18 (4) (2009)
1232–1238.
[20] W.J. Gauderman, J.S. Witte, D.C. Thomas, Family-based association studies,
JNCI Monogr. 1999 (26) (1999) 31–37.
[21] A.E. Cust, H. Schmid, J.A. Maskiell, J. Jetann, M. Ferguson, E.A. Holland, C. Agha-
Hamilton, M.A. Jenkins, J. Kelly, R.F. Kefford, G.G. Giles, B.K. Armstrong, J.F.
Aitken, J.L. Hopper, G.J. Mann, Population-based, case-control-family design to
investigate genetic and environmental inﬂuences on melanoma risk:
australian melanoma family study, Am. J. Epidemiol. 170 (12) (2009) 1541–
1554.
[22] J.L. Hopper, D.T. Bishop, D.F. Easton, Population-based family studies in genetic
epidemiology, Lancet 366 (9494) (2005) 1397–1406.
[23] D. Curtis, Use of siblings as controls in case-control association studies, Ann.
Hum. Genet. 61 (4) (1997) 319–333.
[24] S.S. Wang, J. Luo, W. Cozen, Y. Lu, J. Halley-Sullivan, J. Voutsinas, C. Zhong, J.
Song, J.V. Lacey, D. Weisenburger, L. Bernstein, Sun sensitivity, indoor tanning
and B-cell non-Hodgkin lymphoma risk among Caucasian women in Los
Angeles County, Br. J. Haematol. (2016).
[25] R.L. Milne, E.M. John, J.A. Knight, G.S. Dite, M.C. Southey, G.G. Giles, C. Apicella,
D.W. West, I.L. Andrulis, A.S. Whittemore, J.L. Hopper, The potential value ofsibling controls compared with population controls for association studies of
lifestyle-related risk factors: an example from the Breast Cancer Family
Registry, Int. J. Epidemiol. 40 (5) (2011) 1342–1354.
[26] S. Kaplan, I. Novikov, B. Modan, A methodological note on the selection of
friends as controls, Int. J. Epidemiol. 27 (4) (1998) 727–729.
[27] J.L. Hopper, G. Chenevix-Trench, D.J. Jolley, G.S. Dite, M.A. Jenkins, D.J. Venter,
M.R.E. McCredie, G.G. Giles, Design and analysis issues in a population-Based,
case-control-family study of the genetic epidemiology of Breast cancer and the
co-operative family registry for Breast Cancer Studies (CFRBCS), JNCI Monogr.
1999 (26) (1999) 95–100.
[28] M. National Cancer Institute. Bethesda, SEER Cancer Statistics Factsheets: Non-
Hodgkin Lymphoma. http://seer.cancer.gov/statfacts/html/nhl.html (accessed
04/02/2014.2014).
[29] G.R. Bunin, S. Vardhanabhuti, A. Lin, G.L. Anschuetz, N. Mitra, Practical and
analytical aspects of using friend controls in case–control studies: experience
from a case–control study of childhood cancer, Paediatr. Perinat. Epidemiol. 25
(5) (2011) 402–412.
[30] D.C. Hodgson, M. Pintilie, L. Gitterman, B. DeWitt, C.-A. Buckley, S. Ahmed, K.
Smith, A. Schwartz, R.W. Tsang, M. Crump, W. Wells, A. Sun, M.K.
Gospodarowicz, Fertility among female hodgkin lymphoma survivors
attempting pregnancy following ABVD chemotherapy, Hematol. Oncol. 25 (1)
(2007) 11–15.
[31] W. Cozen, M. Gebregziabher, D.V. Conti, D.J. Van Den Berg, G.A. Coetzee, S.S.
Wang, N. Rothman, L. Bernstein, P. Hartge, A. Morhbacher, S.G. Coetzee, M.T.
Salam, W. Wang, J. Zadnick, S.A. Ingles, Interleukin-6-Related Genotypes, Body
mass index, and risk of multiple myeloma and plasmacytoma, Cancer
Epidemiol. Biomark. Prevent. 15 (11) (2006) 2285–2291.
[32] D.N. Cabral, A.M. Nápoles-Springer, R. Miike, A. McMillan, J.D. Sison, M.R.
Wrensch, E.J. Pérez-Stable, J.K. Wiencke, Population- and community-based
recruitment of African Americans and Latinos: The San Francisco Bay area lung
cancer study, Am. J. Epidemiol. 158 (3) (2003) 272–279.
[33] E. Bandera, U. Chandran, G. Zirpoli, S. McCann, G. Ciupak, C. Ambrosone,
Rethinking sources of representative controls for the conduct of case-control
studies in minority populations, BMC Med. Res. Methodol. 13 (1) (2013) 71.
